Changes in quality of life of food-allergic children from initiation of oral immunotherapy, through up-dosing, upon reaching maintenance and after 6 months of follow-up - 28/02/18
Doi : 10.1016/j.jaci.2017.12.758
Na'ama Epstein-Rigbi, MD 1, Michael R. Goldberg, MD, PhD 2, Michael B. Levy, MD, FAAAAI 3, Liat Nachshon, MD 4, Arnon Elizur, MD 5
1 Institute of Allergy, Immunology and Pediatric Pulmonology, Assaf Harofe Medical Center, Zerifin, Israel
2 Institute of Allergy and Immunolgy, Assaf Harofeh Medical Center, Zerifin, Israel
3 Institute of allergy, immunology and pediatric pulmonology, Assaf Harofe Medical center, Zerifin, Israel, Efrat, Israel
4 Institute of allergy, immunology and pediatric pulmonology, Assaf Harofe Medical center, Zerifin, Israel
5 Department of Pediatrics, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Institute of Asthma Allergy & Immunology, Zerifin, Israel
753
Le texte complet de cet article est disponible en PDF.Plan
© 2017
Publié par Elsevier Masson SAS.
Vol 141 - N° 2S
P. AB240 - février 2018 Retour au numéro
Article précédent
- Nanoallergens: A Nanoparticle Based Platform for Assessment of Immunogenic Peanut Epitopes in a Clinical Population
- Peter E. Deak, Amina Abdul Qayum, Joseph Riehm, Tanyel Kiziltepe, Mark H. Kaplan, Basar Bilgicer
- Usefulness of Component-resolved diagnostics (CRD) in predicting hazelnut allergy in Japanese children
- Yoko Inoue
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?